Conditional mutagenesis of glucocorticoid receptor in the immune sytem

Project Information

Grant agreement ID: QLK2-CT-1999-51404

Project closed

Start date 1 August 2000

End date 31 July 2002

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 146 800,00

EU contribution € 146 800,00

Coordinated by

GERMAN CANCER RESEARCH CENTER
Germany

Objective

Conditional mutagenesis in mice alloxs unravelling glucocorticoid receptor (GR) function in the immune system. I will explore existing and generate novel genetically modified mice. Targets of GR will be identified and their regulation in vivo analysed, providing a basis of improved drug development.
Conditional mutagenesis in mice alloxs unravelling glucocorticoid receptor (GR) function in the immune system. I will explore existing and generate novel genetically modified mice. Targets of GR will be identified and their regulation in vivo analysed, providing a basis of improved drug development.

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › basic medicine › immunology

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

GERMAN CANCER RESEARCH CENTER

• EU contribution: No data
• Address: Im Neuenheimer Feld 280 ; 69120 HEIDELBERG ; Germany
• Total cost: No data